Pourshohod, A., Zeinali, M., Afrakhte, M., & Jamalan, M. (2017). 113: SPECIFIC TARGETING OF HER2-POSITIVE BREAST CANCER CELL LINE (SK-BR3) USING IDARUBICIN-LOADED ANTI-HER2 IMMUNOLIPOSOME. BMJ Open.
Citação norma ChicagoPourshohod, Aminollah, Majid Zeinali, Moslem Afrakhte, and Mostafa Jamalan. "113: SPECIFIC TARGETING OF HER2-POSITIVE BREAST CANCER CELL LINE (SK-BR3) USING IDARUBICIN-LOADED ANTI-HER2 IMMUNOLIPOSOME." BMJ Open 2017.
MLA CitationPourshohod, Aminollah, Majid Zeinali, Moslem Afrakhte, and Mostafa Jamalan. "113: SPECIFIC TARGETING OF HER2-POSITIVE BREAST CANCER CELL LINE (SK-BR3) USING IDARUBICIN-LOADED ANTI-HER2 IMMUNOLIPOSOME." BMJ Open 2017.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.